Outset Medical, Inc.
NMS: OMLive Quote
📈 ZcoreAI Score
Our AI model analyzes Outset Medical, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get OM Z-Score →About Outset Medical, Inc.
Healthcare
Medical Devices
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
📊 Fundamental Analysis
Outset Medical, Inc. demonstrates a profit margin of -68.3%, which is below the sector average, suggesting competitive pressure.
The company recently reported -2.0% revenue growth, which is negative, indicating a recent decline in revenue.
Return on Equity (ROE) is -106.2%, which indicates that capital utilization is currently under pressure.
At a current price of $4.20, OM currently trades near the bottom of its 52-week range (6%), indicating potential value or weakness (Range: $3.00 - $21.98).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$76.91M
Trailing P/E
--
Forward P/E
-1.75
Beta (5Y)
1.96
52W High
$21.98
52W Low
$3.00
Avg Volume
281K
Day High
Day Low